Abacavir CAS 136470-78-5 Assay 99.0%~101.0% API Factory anti-HIV
Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
Igama leKhemikhali: Abacavir
CAS: 136470-78-5
I-nucleoside analog reverse transcriptase inhibitor (NRTI) enamandla esetyenziselwa ukunyanga i-HIV ne-AIDS.
Umgangatho ophezulu we-API, iMveliso yoRhwebo
Igama leMchiza | Abacavir |
Inombolo yeCAS | 136470-78-5 |
Inombolo yeCAT | I-RF-API62 |
Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram |
Ifomula yeemolekyuli | I-C14H18N6O |
Ubunzima beMolekyuli | 286.33 |
Indawo yokunyibilika | 165℃ |
Imeko yokuthumela ngenqanawa | Phantsi koBubushushu be-Ambient |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kuMhlophe oMhlophe wePowder |
Ukuchongwa | (1) IR (2) HPLC (3) Sulfate |
Amanzi | ≤0.50% |
Intsalela kwi-Ingnition | ≤0.20% |
Umda we-Abacavir Enantiomer | ≤0.20% |
1) Izinto ezinxulumeneyo | |
Descyclopropyl Abacavir | ≤0.20% |
Trans-Abacavir | ≤0.20% |
O-Pyrimidinyl Abacavir | ≤0.20% |
t-Butyl Derivate Abacavir | ≤0.20% |
Nakuphi na Ukungacoceki Okungachazwanga | ≤0.10% |
Ukungcola ngokupheleleyo | ≤0.80% |
2) Ubunyulu be-Enantiomeric | Abacavir Enantiomer ≤0.20% |
3) Izinyibilikisi ezishiyekileyo | |
IMethanol | ≤0.30% |
I-acetone | ≤0.50% |
I-Ethanol | ≤0.50% |
Iintsimbi ezinzima | ≤20ppm |
Isivavanyi | I-99.0% ~ 101.0% (ibalwe kwisiseko se-anhydrous kunye ne-solvent free basis) |
Umgangatho woVavanyo | Umgangatho we-United States Pharmacopeia (USP). |
Ukusetyenziswa | API;anti-HIV |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-Abacavir (CAS: 136470-78-5) kunye nomgangatho ophezulu.I-Abacavir API yi-carbocyclic 2'-deoxyguanosine nucleoside reverse transcriptase inhibitor (NRTI) kunye neyeza elichasayo le-HIV elisetyenziselwa ukunyanga usulelo lwe-HIV.Ii-NRTIs zisebenza ngokuthintela i-HIV reverse transcriptase, i-enzayim ye-HIV.Le mveliso yenzelwe unyango lwabantu abadala abosulelwe yi-human immunodeficiency virus (HIV).Amacandelo amathathu amiselweyo (i-Abacavir, i-Lamivudine, kunye ne-Zidovudine) isetyenziswe endaweni ye-monotherapies ezintathu kwiidosi ezifanayo.I-Abacavir, iLamivudine, kunye neZidovudine zodwa zicetyiswa kwiiveki ezi-6-8 ekuqaleni konyango.